HARVARD BIOSCIENCE INC 8-K

What Happened

• On May 12, 2026, Harvard Bioscience, Inc. announced its financial results for the three months ended March 31, 2026 via a press release and scheduled a related conference call for 8:00 AM ET on May 12, 2026. The company furnished the press release as Exhibit 99.1 to the Form 8‑K (Item 2.02).

Key Details

• Filing date: May 12, 2026 (Form 8‑K, Item 2.02).
• Reporting period: three months ended March 31, 2026.
• Conference call: scheduled for 8:00 AM ET on May 12, 2026 to discuss the results.
• Press release announcing the results furnished as Exhibit 99.1 to the 8‑K.

Why It Matters

• Quarterly results releases provide the latest information on earnings, revenue and operating performance; investors should review the press release and listen to the conference call for management commentary and context behind the numbers.
• Because the 8‑K furnishes the release (not files it as an amended report), the press release and call are the immediate sources for material company information for shareholders and analysts.